Sylvia Rosas M.D.

​Dr. Rosas’s primary research focus is on the epidemiology of metabolic and cardiovascular disease complications in the setting of chronic kidney disease including dialysis and renal transplantation. Her research has been funded by the National Institutes of Health (NHLBI and NIDDK) and the Veteran’s Health Administration.

She is a site investigator for the Preventing Early Renal Function Loss (PERL) multi-center study evaluating the efficacy of the urate-lowering drug allopurinol, as compared to placebo, in reducing kidney function loss among subjects with Type 1 diabetes.

She received the 2009 National Hispanic Medical Association Fellow of the Year award for leadership on improving the health of Hispanics. She was the chair for the 2011 NIDDK Network of Minority Research Investigators.​


​Office Phone Number: 1-617-309-2477